Reuters -- Medtronic Inc (MDT.N) missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents prepared for an advisory panel.
Reuters -- Medtronic Inc (MDT.N) missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents prepared for an advisory panel.
